my.bionity.com
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
Agilent Technologies Inc. (NYSE: A) is a global leader in life sciences, diagnostics and applied chemical markets. Now in its 20th year as an independent company delivering insight and innovation toward improving the quality of life,
Agilent instruments, software, services, solutions and people provide trusted answers to customers' most challenging questions.
Merck announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0. “The biopharmaceutical industry i ... > more
Lonza and Agilent Technologies announced a collaboration that has the potential to transform the way personalized cell therapies are manufactured and realized. Product quality and consistency are significant challenges for cell therapy manufacturing due to the complexity of the products and ... > more
Agilent Technologies Inc. announced it has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion. With anticipated tax benefits for Agilent, the net purchase price is expected to be approximately $1.05 billion. The transaction is expected to be compl ... > more
Merck Announces Collaboration with Agilent Technologies
Merck announced that it has entered a collaboration with Agilent Technologies to advance Process Analytical Technologies (PAT). PAT, which is strongly encouraged by global regulatory authorities, is a key enabler for real-time release and Bioprocessing 4.0. “The biopharmaceutical industry i ... more
Lonza and Agilent Announce Strategic Collaboration
Lonza and Agilent Technologies announced a collaboration that has the potential to transform the way personalized cell therapies are manufactured and realized. Product quality and consistency are significant challenges for cell therapy manufacturing due to the complexity of the products and ... more
Agilent Technologies Inc. announced it has signed a definitive agreement to acquire privately-owned BioTek Instruments for $1.165 billion. With anticipated tax benefits for Agilent, the net purchase price is expected to be approximately $1.05 billion. The transaction is expected to be compl ... more
Confident RNA Sample Quality Control and Fragment Analysis
Read how the Agilent Fragment Analyzer, TapeStation and Bioanalyzer systems are successfully used in a variety of workflows, in the genomic community! more
COVID-19 – Vaccine and Drug Development
Deeper Insights to Evaluate Vaccine Candidates Confidently more
COVID-19 & Infectious Disease | When accelerating outcomes with certainty is critical
Pathogens are continuously emerging and evolving. Addressing the threat of new and potentially life-threatening pathogens requires deep understanding more
Agilent Technologies México, S. de R.L. de C.V.
The world’s premier measurement company When measurement matters, engineers, scientists, manufacturers, businesses, researchers, and government agencies rely on Agilent tools and solutions. From home entertainment to homeland security, from food safety to network reliability, and from commu ... more
Agilent Technologies Österreich GmbH
La empresa de metrología líder en el mundo Ya sean ingenieros, científicos, fabricantes, empresas, institutos de investigación o autoridades: Cuando se trata de una metrología óptima, los expertos confían en los instrumentos y soluciones de Agilent. Agilent ofrece sistemas de medición que a ... more
Agilent Technologies India Pvt. Ltd.
The world’s premier measurement company When measurement matters, engineers, scientists, manufacturers, businesses, researchers, and government agencies rely on Agilent tools and solutions. From home entertainment to homeland security, from food safety to network reliability, and from comm ... more
Reasons to be Testing: Transitioning Complex Cancer Genomics into Routine Oncology Practice
Through the delivery of projects including TCGA and ICGC, the lexicon of cancer genomics is nearing completion. Unlocking this knowledge to improve patient outcomes now requires embedding comprehensive genomic profiling into routine oncology practice. more
Advancing on a Sure Path – What's new with NGS @ Agilent?
Topics discussed will include:New options for SureSelect library preparationNew Bait design algorithm and improved manufacturingUpcoming product releasesAutomated workflow to meet the needs of today’s large labs more
